Identifying biomarkers for chronic pain after breast cancer treatment
sCANsens: Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment
This study is trying to find specific markers in the body that can help understand and manage chronic pain in women who have survived breast cancer treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 25 Years to 65 Years |
| Sex | Female |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 1 site (Wilrijk, Antwerpen) |
| Trial ID | NCT05507034 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify biomarkers associated with chronic pain experienced by women after breast cancer treatment. It focuses on understanding the prevalence and characteristics of chronic pain in this population, which affects up to 40% of survivors. By mapping predictive, prognostic, and diagnostic biomarkers, the study seeks to enhance the understanding of pain management in breast cancer survivors. The research will involve evaluating patients who are pain-free at enrollment but may develop chronic pain over time.
Who should consider this trial
Good fit: Ideal candidates for this study are women with unilateral breast cancer who are experiencing low levels of pain at the time of enrollment.
Not a fit: Patients with pre-existing pain conditions or major neurological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for breast cancer survivors, enhancing their quality of life.
How similar studies have performed: While chronic pain after breast cancer is a recognized issue, this specific approach to identifying biomarkers is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Unilateral breast cancer * Pain at enrollment \<3/10 on average during the past week * First cancer diagnosis Exclusion Criteria: * Pre-existing pain conditions * major pre-existing neurological disorders * No recurrent cancer or metastasis * No previous surgery in area
Where this trial is running
Wilrijk, Antwerpen
- University Hospital Antwerpen — Wilrijk, Antwerpen, Belgium (Recruiting)
Study contacts
- Principal investigator: Mira Meeus, Prof. — Universiteit Antwerpen
- Study coordinator: Mira Meeus, Prof.
- Email: mira.meeus@uantwerpen.be
- Phone: +32 3 265 2403
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.